ARECOR THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.50 GBX | 0.00% |
|
0.00% | -20.41% |
| Jan. 10 | Arecor Therapeutics shares tumble as plans Tetris wind-down | AN |
| Jan. 10 | Arecor Therapeutics to Shutter Tetris Pharma Unit; Ends License Deal with Xeris | MT |
EPS & Dividend: Arecor Therapeutics plc
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.27 | -0.32 | -0.28 | -0.3 | -0.2 | - |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 4.0000 | 2.4000 | 1.8250 | 0.5850 | 0.5850 | 0.5850 |
| Nbr of stocks (in thousands) | 27,835 | 30,618 | 30,627 | 37,757 | 37,757 | - |
| Announcement Date | 4/25/22 | 4/20/23 | 5/16/24 | - | - | - |
1GBP in Million2GBP
Estimates
Upcoming events: Arecor Therapeutics plc
| 2025-04-27 | Q4 2024 Earnings Release (Projected) |
| 2025-09-17 | Q2 2025 Earnings Release (Projected) |
| 2026-04-26 | Q4 2025 Earnings Release (Projected) |
| 2026-09-16 | Q2 2026 Earnings Release (Projected) |
| Yield | Yield | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -1.95x | 3.84x | 3.43x | ||
| +0.79% | +0.90% | 49x | 4.33x | 6.7x | ||
| -.--% | -.--% | 28x | 5.55x | 3.23x | ||
| +0.27% | +0.27% | 89.45x | 2.3x | 11.25x | ||
| -.--% | -.--% | 23.54x | 1.72x | 2.36x | ||
| -.--% | -.--% | 14.91x | 2.35x | 4.96x | ||
| -.--% | -.--% | -3.83x | 1.33x | 1.89x | ||
| +0.41% | +0.42% | 65.55x | 5.35x | 10.14x | ||
| -.--% | -.--% | 29.05x | 11.01x | 4.98x | ||
| -.--% | -.--% | 64.21x | 2.83x | 5.46x | ||
| Average | +0.15% | +0.16% | 35.79x | 4.06x | 5.44x | |
| Weighted average by Cap. | +0.25% | +0.28% | 42.27x | 4.03x | 5.83x |
